Thrombocytopenia screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Thrombocytopenia}} | {{Thrombocytopenia}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for thrombocytopenia. | |||
==Screening== | ==Screening== | ||
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for thrombocytopenia. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 11:41, 1 October 2018
|
Thrombocytopenia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Thrombocytopenia screening On the Web |
|
American Roentgen Ray Society Images of Thrombocytopenia screening |
|
Risk calculators and risk factors for Thrombocytopenia screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for thrombocytopenia.
Screening
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for thrombocytopenia.